NovoCure Ltd — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-03-02

Reporting Person: Scannell Timothy J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-02	Options to Buy Ordinary Shares	$153.09	A	7929	Acquired	2031-03-01	Ordinary Shares (7929.0)	Direct

Footnotes

F1: These stock options will vest in equal parts on the first, second and third anniversary of the grant date.